SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,393 | -49.0% | 194,332 | +2.7% | 0.00% | -50.0% |
| Q2 2023 | $906,056 | +15238.7% | 189,181 | +18055.6% | 0.00% | – |
| Q1 2023 | $5,907 | -15.6% | 1,042 | -22.4% | 0.00% | – |
| Q4 2022 | $7,000 | -75.9% | 1,342 | -70.7% | 0.00% | – |
| Q3 2022 | $29,000 | +866.7% | 4,583 | +339.8% | 0.00% | – |
| Q2 2022 | $3,000 | -57.1% | 1,042 | +5.0% | 0.00% | – |
| Q1 2022 | $7,000 | -30.0% | 992 | -16.8% | 0.00% | – |
| Q4 2021 | $10,000 | +42.9% | 1,192 | +20.5% | 0.00% | – |
| Q3 2021 | $7,000 | -81.6% | 989 | -37.3% | 0.00% | – |
| Q2 2021 | $38,000 | +18.8% | 1,577 | +1.0% | 0.00% | – |
| Q1 2021 | $32,000 | +88.2% | 1,561 | +116.2% | 0.00% | – |
| Q4 2020 | $17,000 | -29.2% | 722 | -16.9% | 0.00% | – |
| Q3 2020 | $24,000 | -52.9% | 869 | -91.8% | 0.00% | – |
| Q2 2020 | $51,000 | +34.2% | 10,600 | 0.0% | 0.00% | – |
| Q1 2020 | $38,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |